Ductal Carcinoma In Situ

Gender Neutral
Type Module
Testing Phase I / II - in development
Principal investigator(s)
Edward Chow
University of Toronto
Toronto, Canada
Study coordinator(s)
Henry CY Wong
Princess Margaret Hospital
Kowloon, Hong Kong SAR China
, Adrian Wai Chan
British Columbia Cancer Agency
Vancouver, Canada

Project summary

This project aims to

1)​To carry out an evaluation of the EORTC QLQ-BR 45 (adapting for DCIS and for suitability of use in DCIS patients)
2)​To provide recommendations to the EC on a suitable assessment approach to assess HRQoL in DCIS patients

Achievements

Healthcare professional survey on QoL issues in patients with DCIS is ongoing.

Future plans

Patient survey are ongoing, and is planned to complete by the end of September.

For patients

Currently, there is not a special tool to assess the quality of life of patients with ductal carcinoma in situ (DCIS). Some studies have tried to use multiple surveys to help, but these can take a long time to fill out and might not really address what DCIS patients are going through. Researchers think DCIS patients might have different concerns compared to other breast cancer patients, so they might need a specific tool just for them. The goal of this project is to improve a tool called EORTC QLQ-BR45, making sure it fits DCIS patients better and adding new questions that are important for them.

Go to Top